STOCK TITAN

Director Ethan Nadelmann granted 6,648 Green Thumb (GTBIF) shares as award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Green Thumb Industries Inc. director Ethan Nadelmann reported an equity award of 6,648 Subordinate Voting Shares of the company. The shares were acquired as a grant or award at a stated price of $0.00 per share, indicating a non-cash compensation grant rather than an open-market purchase. Following this transaction, Nadelmann’s directly held Subordinate Voting Shares increased to 62,994 shares.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Nadelmann Ethan

(Last) (First) (Middle)
325 W. HURON ST.
SUITE 700

(Street)
CHICAGO IL 60654

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Green Thumb Industries Inc. [ GTII/GTBIF ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Subordinate Voting Shares 03/01/2026 A 6,648 A $0 62,994 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Kathryn A. Lloyd, Attorney-in-Fact 03/03/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Green Thumb Industries (GTBIF) report for Ethan Nadelmann?

Green Thumb Industries reported that director Ethan Nadelmann received an award of 6,648 Subordinate Voting Shares. The transaction was coded as a grant or other acquisition, reflecting stock-based compensation rather than an open-market trade.

How many Green Thumb Industries (GTBIF) shares did Ethan Nadelmann acquire?

Ethan Nadelmann acquired 6,648 Subordinate Voting Shares of Green Thumb Industries. This was reported as a grant or award, increasing his directly held position as part of his compensation arrangement with the company.

At what price were Ethan Nadelmann’s GTBIF shares granted?

The 6,648 Subordinate Voting Shares granted to Ethan Nadelmann were reported at $0.00 per share. This indicates a non-cash equity award, typical for director or executive compensation rather than a market purchase.

What is Ethan Nadelmann’s Green Thumb Industries shareholding after this Form 4?

After receiving the 6,648-share award, Ethan Nadelmann directly holds 62,994 Subordinate Voting Shares of Green Thumb Industries. This figure represents his direct ownership position following the reported grant transaction.

Was Ethan Nadelmann’s GTBIF transaction a purchase or a grant?

The transaction was a grant, not a market purchase. It is coded as a grant, award, or other acquisition, meaning Nadelmann received 6,648 shares as compensation rather than buying them on the open market.

What type of security did Ethan Nadelmann receive from Green Thumb Industries?

Ethan Nadelmann received Subordinate Voting Shares of Green Thumb Industries. These are the company’s equity securities, and the Form 4 shows 6,648 such shares granted to him as an award.
Green Thum

OTC:GTBIF

GTBIF Rankings

GTBIF Latest News

GTBIF Latest SEC Filings

GTBIF Stock Data

1.75B
201.97M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Chicago